NRX Pharmaceuticals
NRXP
7 hedge funds and large institutions have $5.22M invested in NRX Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
2.85% less ownership
Funds ownership: 4.16% → 1.31% (-2.9%)
46% less funds holding
Funds holding: 13 → 7 (-6)
80% less capital invested
Capital invested by funds: $25.5M → $5.22M (-$20.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$2.93M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.21K |
| 3 |
BCM
Bluefin Capital Management
New York
|
+$2.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$5.49M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$4.58M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$3M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$2.12M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$2.05M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCM
1
Rivernorth Capital Management
West Palm Beach,
Florida
| $2.01M | -$1.85M | -17,230 | -72% |
|
|
MF
2
Magnetar Financial
Evanston,
Illinois
| $1.91M | -$3M | -28,000 | -60% |
|
|
PMAM
3
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| $1.09M | +$2.93M | +27,340 | +1,028% |
|
|
YCM
4
Yakira Capital Management
Westport,
Connecticut
| $177K | -$1.59M | -14,859 | -90% |
|
|
5
UBS Group
Zurich,
Switzerland
| $22K | +$3.21K | +30 | +17% |
|
|
BCM
6
Bluefin Capital Management
New York
| $7K | +$2.14K | +20 | +0.2% |
|
7
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $4K | – | – | – |
|
|
PAMP
8
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$5.49M | -51,750 | Closed |
|
|
OAM
9
Oxford Asset Management
Oxford,
United Kingdom
| – | -$4.58M | -43,160 | Closed |
|
|
AA
10
AQR Arbitrage
Greenwich,
Connecticut
| – | -$2.12M | -20,000 | Closed |
|
|
KPF
11
K2 Principal Fund
Toronto,
Ontario, Canada
| – | -$2.05M | -19,309 | Closed |
|
|
WAM
12
Weiss Asset Management
Boston,
Massachusetts
| – | -$876K | -8,267 | Closed |
|
NRXP Hedge Fund Activity: Q1 2020 in Review
7 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q1 2020, worth a combined $5.22M — down 80% from $25.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NRXP and 0 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Picton Mahoney Asset Management, adding an estimated $2.93M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $5.49M sold.
- 7 institutional investors held NRX Pharmaceuticals (NRXP) as of Q1 2020, down from 13 in Q4 2019.
- Funds reported $5.22M of NRX Pharmaceuticals stock for Q1 2020, down 80% quarter-over-quarter.
- 0 funds opened new NRX Pharmaceuticals positions in Q1 2020 and 5 closed out, a net change of -5 holders.
- The largest NRX Pharmaceuticals buyer in Q1 2020 was Picton Mahoney Asset Management, an estimated $2.93M added.
- The largest NRX Pharmaceuticals seller in Q1 2020 was Polar Asset Management Partners, an estimated $5.49M sold.
Based on aggregated 13F filings for Q1 2020.